The Operating System for AI in Regulated Industries

Healthcare

Life Sciences

Governments

Play video

The Operating System for AI in Regulated Industries

Healthcare

Life Sciences

Governments

Play video

The last frontier. And the most impactful.
The last frontier. And the most impactful.
The last frontier. And the most impactful.
The software industry has failed the most important sectors of civilisation

Healthcare systems run on legacy software. Life sciences still run clinical trials through email and legacy tools. Government agencies manage crises with PDFs.

General-purpose AI cannot operate inside regulated environments without a regulated home

A model that cannot be audited, cleared, and deployed inside a compliant product in healthcare or government is not a feature gap. It is a decade of regulatory work.

Building the critical infrastructure for AI in the world's largest industry

Total market size by 2030

~$20 Trillion

Healthcare will soon be a $20 trillion market.

Potential for displacement

~$10 Trillion

Within healthcare, there is potential to displace $10 trillion of spending with AI-driven, agentic technology.

One platform.
Deployed globally.

Infrastructure for Health & Research at scale

The Huma Cloud Platform is the heart of Huma. A governed model of reality that unifies clinical, operational, and research data so teams can ship mission-critical software fast, orchestrate workflows, and automate decisions safely across care and life sciences.

Regulatory coverage that compounds

One cleared platform, certified and registered worldwide. The Huma Cloud Platform is already regulated: a library of clinical applications ready to deploy. Our Forward Deployment Engineers build the remaining capabilities for each customer, while our regulatory engine transforms those innovations into FDA Class II and EU MDR-regulated products in weeks rather than years.

Huma is the platform behind the world's leading AI and digital-first health products. Every deployment is supported by an AI-driven, software-defined, federated operating model.

Enterprise transformation, delivered in three phases

A proven operating model to design, deploy, and scale regulated AI health services – fast, safely, and at national scale.

Enterprise transformation, delivered in three phases

A proven operating model to design, deploy, and scale regulated AI health services – fast, safely, and at national scale.

Enterprise transformation, delivered in three phases

A proven operating model to design, deploy, and scale regulated AI health services – fast, safely, and at national scale.

What our partners say
  • NHSX (UK)

    “This is a great example of how new technology is supporting healthcare professionals to provide the right care at the right time.”

    NHSX (UK)

    Tara Donnelly

    Chief Digital Officer

    “This is a great example of how new technology is supporting healthcare professionals to provide the right care at the right time.”

  • West Hertfordshire Hospitals NHS Trust

    “The remote patient monitoring offers a promising solution to help us scale our efforts to the growing needs of our community.”

    West Hertfordshire Hospitals NHS Trust

    Dr Matthew Knight

    Respiratory Consultant

    “The remote patient monitoring offers a promising solution to help us scale our efforts to the growing needs of our community.”

  • NHS Primary Care (UK)

    “Using Hi Scribe to transcribe my medical notes has transformed my day – saving me 2–3 minutes every consultation and allowing me to focus fully on my patients.”

    NHS Primary Care (UK)

    Dr Ross Dyer-Smith

    General Practitioner

    “Using Hi Scribe to transcribe my medical notes has transformed my day – saving me 2–3 minutes every consultation and allowing me to focus fully on my patients.”

  • Wheel (US)

    “With Hi Scribe now integrated into Horizon, we’re excited to bring this kind of transformative AI technology to virtual care in the U.S.”

    Wheel (US)

    Michelle Davey

    CEO & Founder

    “With Hi Scribe now integrated into Horizon, we’re excited to bring this kind of transformative AI technology to virtual care in the U.S.”

  • University of Cambridge (MRC Epidemiology Unit)

    “Here we saw not only great enrolment and retention, but also engagement which has helped us create a useful checklist for other researchers to follow.”

    University of Cambridge (MRC Epidemiology Unit)

    Dr Kirsten Rennie

    Senior Research Associate

    “Here we saw not only great enrolment and retention, but also engagement which has helped us create a useful checklist for other researchers to follow.”

  • Banner Medical Group (US)

    “This level of clearance gives us confidence that we are working with a highly regulated, safe and evidence-based platform.”

    Banner Medical Group (US)

    Dr Rishi Patel

    Cardiology Service Line Medical Director

    “This level of clearance gives us confidence that we are working with a highly regulated, safe and evidence-based platform.”

  • Bayer (Middle East & Pakistan)

    “Our partnership with Huma to expand the Heart Health Risk Assessment tool to Saudi Arabia underscores our commitment to leveraging digital health solutions for preventive care.”

    Bayer (Middle East & Pakistan)

    Mohamed Galal

    Vice President

    “Our partnership with Huma to expand the Heart Health Risk Assessment tool to Saudi Arabia underscores our commitment to leveraging digital health solutions for preventive care.”

  • Bayer (Saudi Arabia)

    “Our collaboration with Huma is a testament to Bayer’s commitment to advancing digital health solutions that can make a real difference in people’s lives.”

    Bayer (Saudi Arabia)

    Maged ElShazly

    Managing Director & Country Commercial Lead

    “Our collaboration with Huma is a testament to Bayer’s commitment to advancing digital health solutions that can make a real difference in people’s lives.”

  • Servier Pharmaceuticals

    “This app is one example of the ‘beyond the pill’ digital solutions we are working to provide to patients, caregivers, advocacy groups and others.”

    Servier Pharmaceuticals

    Wendy Poage

    VP, Patient Office

    “This app is one example of the ‘beyond the pill’ digital solutions we are working to provide to patients, caregivers, advocacy groups and others.”

  • AstraZeneca

    “With the latest advances in AI and machine learning combined with a streamlined patient experience through the use of Huma’s platform, AstraZeneca can extend its evidence generation capabilities.”

    AstraZeneca

    Karan Arora

    Director, Digital Health

    “With the latest advances in AI and machine learning combined with a streamlined patient experience through the use of Huma’s platform, AstraZeneca can extend its evidence generation capabilities.”

In UK Parliament: Huma's CEO, Dan Vahdat, calls to back British AI and healthcare

A clear message to Parliament: invest in UK AI now, unlock £300bn value, strengthen sovereignty, and build the future of healthcare.

Case studies